“Alzheimer’s/Tauopathies: Advancing a First-in-Class Small Molecule Through Preclinical and Human Trials”
Frank M. Longo, MD, PhD
George and Lucy Becker Professor and Chair
Department of Neurology and Neurological Sciences
Stanford University School of Medicine
Attendees will learn about:
1. Amyloid-based therapies for Alzheimer’s disease;
2. Strategies for translating preclinical trials to human trials;
3. Emerging biomarkers for Alzheimer’s trials.
Accreditation: The University of California, San Francisco (UCSF) School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation: UCSF designates this live activity for a maximum of 22 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The above credit is inclusive of all Memory and Aging Center Grand Rounds sessions offered January 2020 through June 2020. (1 credit per each 1-hour grand rounds session throughout the year).
NOTE: You must sign in to qualify for CME Credit
Grand Rounds presentations are for educational purposes and intended for a professional audience. This activity is not commercially supported.
Friday, January 24 at 8:00am to 9:00am
Rock Hall, Pottruck Auditorium, RH 102
1550 4th Street, San Francisco, CA 94158